Replies to post #111000 on Biotech Values

[10nisman]

I don't think there is much doubt that this raise was done for fear of Teva. It may be true that TEVA cannot possibly meet the FDA standard unless they cheat and steal MNTA's IP.

Fear? MNTA management obviously has been and always will respect its competitors abilities, however, MNTA is NOT managing its business based on fear. Using a word like fear in this context is ridiculous, IMHO. The capital raise was MNTA's management way of removing potential risk around an event that it has zero visibility or control over (a tLovenox approval). Managing risk and being fearful are not the same. IMO, if anyone is fearful its TEVA who just issued its 3rd CP.

10nis